APPLICATION
ANDA078485
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-28
LATEST ACTION
2025-10-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ANASTROZOLEDiscontinued
ANASTROZOLE 1MG · TABLET · ORAL
Approval history
2025-10-24Labeling · Supplement 9 · standardAP
2025-02-21Labeling · Supplement 8 · standardAP
2015-11-05Labeling · Supplement 7 · standardAP
2015-11-05Labeling · Supplement 6 · standardAP
2011-11-14Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.